BLEPHAMIDE is a Ophthalmic Ointment in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Sulfacetamide Sodium; Prednisolone Acetate.
| Product ID | 0023-0313_376f9d35-04d0-4089-b303-99c0d7671ae7 | 
| NDC | 0023-0313 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | BLEPHAMIDE | 
| Generic Name | Sulfacetamide Sodium And Prednisolone Acetate | 
| Dosage Form | Ointment | 
| Route of Administration | OPHTHALMIC | 
| Marketing Start Date | 1987-01-01 | 
| Marketing Category | ANDA / ANDA | 
| Application Number | ANDA087748 | 
| Labeler Name | Allergan, Inc. | 
| Substance Name | SULFACETAMIDE SODIUM; PREDNISOLONE ACETATE | 
| Active Ingredient Strength | 100 mg/g; mg/g | 
| Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Sulfonamide Antibacterial [EPC],Sulfonamides [CS] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 1987-01-01 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | ANDA | 
| Application Number | ANDA087748 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | GM | 
| Marketing Start Date | 1987-01-01 | 
| Ingredient | Strength | 
|---|---|
| SULFACETAMIDE SODIUM | 100 mg/g | 
| SPL SET ID: | c68ebddc-dcb5-4695-a66b-d03a65a110f6 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0023-0313 | BLEPHAMIDE | sulfacetamide sodium and prednisolone acetate | 
| 11980-022 | BLEPHAMIDE | sulfacetamide sodium and prednisolone acetate | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  BLEPHAMIDE  72119340  0724725 Live/Registered | Allergan Pharmaceuticals, Inc. 1961-05-05 |